MDMA and metabolite disposition in expectorated oral fluid after controlled oral MDMA administration

Therapeutic Drug Monitoring

Volumn 33, Issue 5, 2011, Pages 602-608

  Barnes, Allan J ^a   Scheidweiler, Karl B ^a   Kolbrich Spargo, Erin A ^a,b   Gorelick, David A ^a   Goodwin, Robert S ^a   Huestis, Marilyn A ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b Southwest Institute of Forensic Science Dallas   (United States)

Author keywords

alternative matrix; DRUID; MDMA; oral fluid; saliva

Indexed keywords

3 O METHYL ALPHA METHYLDOPAMINE; 3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4 HYDROXY 3 METHOXYMETHAMPHETAMINE; DRUG METABOLITE; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ARTICLE; DOUBLE BLIND PROCEDURE; DRUG DETERMINATION; DRUG MONITORING; DRUG SCREENING; FEMALE; HUMAN; HUMAN EXPERIMENT; LIMIT OF QUANTITATION; MALE; MASS FRAGMENTOGRAPHY; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SALIVA LEVEL; SUBSTANCE ABUSE;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; SALIVA; YOUNG ADULT;

EID: 84860389844     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e3182281975     Document Type: Article

References (27)

1. Parrott AC. Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research. Hum Psychopharmacol. 2001;16:557-577. (Pubitemid 34040989)
2. Green AR, Mechan AO, Elliott JM, et al. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol Rev. 2003;55:463-508. (Pubitemid 37013213)
3. Schifano F. A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities. Psychopharmacology (Berl). 2004;173:242-248. (Pubitemid 38703797)
4. Substance abuse and mental health services administration. Results From the 2009 National Survey on Drug Use and Health: National Findings. Office of Applied Studies. NSDUH Series H-38B. DHHS Publication No. SMA 10-4856. Rockville, MD: Department of Health and Human Services (DHHS); 2010.
5. Department of Transportation-National Highway Traffic Safety Administration. 2007 National Roadside Survey of Alcohol and Drug Use by Drivers: Drug Results. Washington, DC: DOT Publication No. HS 811-249; 2008.
6. Bosker WM, Huestis MA. Oral fluid testing for drugs of abuse. Clin Chem. 2009;55:1910-1931.
7. Drummer OH. Drug testing in oral fluid. Clin Biochem Rev. 2006;27:147-159.
8. Kintz P, Samyn N. Use of alternative specimens: drugs of abuse in saliva and doping agents in hair. Ther Drug Monitor. 2002;24:239-246. (Pubitemid 34246553)
9. Toennes SW, Steinmeyer S, Maurer HJ, et al. Screening for drugs of abuse in oral fluid-correlation of analysis results with serum in forensic cases. J Anal Toxicol. 2005;29:22-27. (Pubitemid 40128941)
10. Drummer OH. Introduction and review of collection techniques and applications of drugtestingoforalfluid.Ther DrugMonitor. 2008;30:203-206. (Pubitemid 351521648)
11. Bush DM. The U. S. mandatory guidelines for federal workplace drug testing programs: current status and future considerations. Forensic Sci Int. 2008;174:111-119.
12. Pil K, Raes E, Neste TVd, et al. Toxicological analyses in the DRUID epidemiological studies: analytical methods, target analytes and analytical cut-offs. The International Association of Forensic Toxicology Annual Meeting; August 27-30, 2007; Seattle, WA.
13. Walsh JM, Verstraete AG, Huestis MA, et al. Guidelines for research on drugged driving. Addiction. 2008;103:1258-1268. (Pubitemid 352009056)
14. Samyn N, De Boeck G, Wood M, et al. Plasma, oral fluid and sweat wipe ecstasy concentrations in controlled and real life conditions. Forensic Sci Int. 2002;128:90-97.
15. Wood M, Laloup M, Ramirez Fernandez Mdel M, et al. Quantitative analysis of multiple illicit drugs in preserved oral fluid by solid-phase extraction and liquid chromatography-tandem mass spectrometry. Forensic Sci Int. 2005;150:227-238. (Pubitemid 41583227)
16. Navarro M, Pichini S, Farre M, et al. Usefulness of saliva for measurement of 3,4-methylenedioxymethamphetamine and its metabolites: correlation with plasma drug concentrations and effect of salivary pH. Clin Chem. 2001;47:1788-1795. (Pubitemid 32881191)
17. Scheidweiler KB, Huestis MA. Avalidated gas chromatographic-electron impact ionization mass spectrometric method for methylenedioxymethamphetamine (MDMA), methamphetamine and metabolites in oral fluid. J Chromatogr B. 2006;835:90-99.
18. Krouwer JS, Rabinowitz R. How to improve estimates of imprecision. Clin Chem. 1984;30:290-292. (Pubitemid 14190285)
19. Kolbrich EA, Goodwin RS, Gorelick DA, et al. Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults. Ther Drug Monitor. 2008;30:320-332.
20. de la Torre R, Farre M, Roset PN, et al. Pharmacology of MDMA in humans. Ann New York Acad Sci. 2000;914:225-237.
21. Mas M, Farre M, de la Torre R, et al. Cardiovascular and neuroendocrine effects and pharmacokinetics of 3,4-methylenedioxymethamphetamine in humans. J Pharmacol Exp Ther. 1999;290:136-145. (Pubitemid 29302313)
22. Cone EJ. Saliva testing for drugs of abuse. Ann New York Acad Sci. 1993; 694:91-127. (Pubitemid 23298235)
23. Pichini S, Navarro M, Farre M, et al. On-site testing of 3,4-methylenedioxymethamphetamine (ecstasy) in saliva with drugwipe and drugread: a controlled study in recreational users. Clin Chem. 2002;48:174-176. (Pubitemid 34038137)
24. Kraemer T, Maurer HH. Toxicokinetics of amphetamines: metabolism and toxicokinetic data of designer drugs, amphetamine, methamphetamine, and their N-alkyl derivatives. Ther Drug Monitor. 2002;24:277-289. (Pubitemid 34248035)
25. Silcott P, Silcott M, The Book of E: All about Ecstasy. London, England; Omnibus Press; 2000.
26. Farre M, de la Torre R, Mathuna BO, et al. Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokinetics. Psychopharmacology (Berlin). 2004;173:364-375. (Pubitemid 38703810)
27. de la Torre R, Farre M, Ortuno J, et al. Non-linear pharmacokinetics of MDMA ("ecstasy") in humans. J Clin Pharmacol. 2000;49:104-109. (Pubitemid 30068287)